Miguel López-Botet

18PUBLICATIONS
54CO-AUTHORS
Molecular targetsImmunology not elsewhere classifiedInnate immunityImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 07, 2026
The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective.

Miguel López-Botet, Carlos Vilches, Aura Muntasell

|May 10, 2025
Human Cytomegalovirus Antigen Presentation by HLA-G in Infected Cells.

Mireia Altadill, Iñaki Álvarez, Michelle Ataya

|Mar 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.

Anna Rea, Sara Santana-Hernández, Javier Villanueva

|Nov 24, 2024
NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV.

Judit Asenjo, Manuela Moraru, Karima Al-Akioui-Sanz

|Apr 19, 2022
Characterization of KIR<sup>+</sup> NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C.

Raffaella Meazza, Michela Falco, Paolo Canevali

|Apr 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

Michela Falco, Raffaella Meazza, Claudia Alicata

Pageof 3

Frequent Collaborators

10 joint publications

Aura Muntasell

4 joint publications

Carlos Vilches

4 joint publications

Michelle Ataya

4 joint publications

Laura Llinàs-Mallol